Paloma Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-9,569
| Closed | -$512K | – | 1773 |
|
|
2020
Q4 | $512K | Buy |
+9,569
| New | +$512K | 0.01% | 714 |
|
|
2020
Q3 | – | Sell |
-252,100
| Closed | -$12.2M | – | 1823 |
|
|
2020
Q2 | $12.2M | Buy |
+252,100
| New | +$12.2M | 0.21% | 67 |
|
|
2020
Q1 | – | Sell |
-10,883
| Closed | -$466K | – | 1066 |
|
|
2019
Q4 | $466K | Buy |
+10,883
| New | +$466K | 0.01% | 1177 |
|
|
2019
Q3 | – | Sell |
-25,673
| Closed | -$686K | – | 1564 |
|
|
2019
Q2 | $686K | Sell |
25,673
-16,854
| -40% | -$450K | 0.01% | 694 |
|
|
2019
Q1 | $1.14M | Buy |
42,527
+14,339
| +51% | +$385K | 0.03% | 453 |
|
|
2018
Q4 | $456K | Buy |
+28,188
| New | +$456K | 0.01% | 509 |
|
|
2017
Q4 | – | Sell |
-18,200
| Closed | -$686K | – | 1228 |
|
|
2017
Q3 | $686K | Buy |
+18,200
| New | +$686K | 0.01% | 827 |
|
|
2017
Q2 | – | Sell |
-21,125
| Closed | -$726K | – | 1606 |
|
|
2017
Q1 | $726K | Buy |
+21,125
| New | +$726K | 0.01% | 989 |
|
|
2016
Q4 | – | Sell |
-28,636
| Closed | -$911K | – | 1488 |
|
|
2016
Q3 | $911K | Sell |
28,636
-110,746
| -79% | -$3.52M | 0.01% | 681 |
|
|
2016
Q2 | $4.52M | Buy |
+139,382
| New | +$4.52M | 0.05% | 189 |
|
|
2016
Q1 | – | Sell |
-6,449
| Closed | -$229K | – | 1437 |
|
|
2015
Q4 | $229K | Buy |
+6,449
| New | +$229K | 0.01% | 1153 |
|
|
2015
Q3 | – | Sell |
-7,400
| Closed | -$310K | – | 1252 |
|
|
2015
Q2 | $310K | Buy |
+7,400
| New | +$310K | 0.01% | 1104 |
|
|
2014
Q4 | – | Sell |
-11,650
| Closed | -$288K | – | 1037 |
|
|
2014
Q3 | $288K | Sell |
11,650
-12,679
| -52% | -$313K | 0.01% | 663 |
|
|
2014
Q2 | $550K | Buy |
+24,329
| New | +$550K | 0.02% | 481 |
|